News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
686,276 Results
Type
Article (39082)
Company Profile (279)
Press Release (646915)
Section
Business (203885)
Career Advice (1992)
Deals (35367)
Drug Delivery (86)
Drug Development (80814)
Employer Resources (168)
FDA (16092)
Job Trends (14806)
News (344584)
Policy (32440)
Tag
Academia (2530)
Alliances (49111)
Alzheimer's disease (1239)
Approvals (16025)
Artificial intelligence (141)
Bankruptcy (353)
Best Places to Work (11548)
Biotechnology (200)
Breast cancer (135)
Cancer (1145)
Cardiovascular disease (103)
Career advice (1660)
Cell therapy (240)
Clinical research (64350)
Collaboration (407)
Compensation (211)
COVID-19 (2533)
C-suite (101)
Data (1175)
Diabetes (157)
Diagnostics (6156)
Earnings (84845)
Employer resources (146)
Events (109710)
Executive appointments (326)
FDA (16660)
Funding (372)
Gene therapy (182)
GLP-1 (581)
Government (4327)
Healthcare (18681)
Infectious disease (2619)
Inflammatory bowel disease (108)
Interviews (308)
IPO (16311)
Job creations (3625)
Job search strategy (1417)
Layoffs (414)
Legal (7854)
Lung cancer (174)
Manufacturing (179)
Medical device (13187)
Medtech (13192)
Mergers & acquisitions (19155)
Metabolic disorders (410)
Neuroscience (1527)
NextGen Class of 2024 (6499)
Non-profit (4464)
Northern California (1539)
Obesity (234)
Opinion (179)
Patents (108)
People (56321)
Phase I (19992)
Phase II (28340)
Phase III (21133)
Pipeline (475)
Postmarket research (2555)
Preclinical (8504)
Radiopharmaceuticals (236)
Rare diseases (228)
Real estate (5890)
Regulatory (21561)
Research institute (2309)
Resumes & cover letters (349)
Southern California (1335)
Startups (3562)
United States (13939)
Vaccines (553)
Weight loss (169)
Date
Today (108)
Last 7 days (381)
Last 30 days (3263)
Last 365 days (35504)
2024 (33366)
2023 (40074)
2022 (51175)
2021 (55714)
2020 (54087)
2019 (46541)
2018 (35020)
2017 (32111)
2016 (31480)
2015 (37554)
2014 (31321)
2013 (26348)
2012 (28570)
2011 (29263)
2010 (27329)
Location
Africa (713)
Arizona (193)
Asia (37172)
Australia (6065)
California (3449)
Canada (1336)
China (268)
Colorado (151)
Connecticut (159)
Europe (79584)
Florida (481)
Georgia (122)
Illinois (351)
Indiana (204)
Kansas (96)
Maryland (595)
Massachusetts (2711)
Michigan (160)
Minnesota (277)
New Jersey (992)
New York (996)
North Carolina (714)
Northern California (1539)
Ohio (142)
Pennsylvania (866)
South America (1091)
Southern California (1335)
Texas (495)
Utah (92)
Washington State (371)
686,276 Results for "perkinelmer inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Deals
PerkinElmer Acquires Covaris to Create an Innovation-Led, Global Life-Sciences and Diagnostics Platform
PerkinElmer today announced that it has acquired Covaris, a leading developer of solutions to empower life science innovations.
December 4, 2023
·
4 min read
Business
PerkinElmer Board Declares Quarterly Dividend - April 25, 2023
The Board of Directors of PerkinElmer, Inc. declared a regular quarterly dividend of $0.07 per share of common stock.
April 25, 2023
·
1 min read
Business
PerkinElmer to Hold Earnings Call on Thursday, May 11, 2023
PerkinElmer Inc. (NYSE: PKI), today announced that it will release its first quarter 2023 financial results prior to market open on Thursday, May 11, 2023.
April 12, 2023
·
1 min read
Business
PerkinElmer Board Declares Quarterly Dividend - Jan 26, 2023
The Board of Directors of PerkinElmer, Inc. declared a regular quarterly dividend of $0.07 per share of common stock.
January 26, 2023
·
1 min read
Genetown
PerkinElmer to Present at Upcoming Investor Conferences - February 22, 2023
PerkinElmer Inc. , (NYSE: PKI), a global leader committed to innovating for a healthier world, today announced that the Company will present at the Cowen 43rd Annual Health Care Conference and the Barclays Global Healthcare Conference.
February 22, 2023
·
1 min read
Genetown
PerkinElmer to Present at KeyBanc Capital Markets Life Sciences & MedTech Investor Forum
PerkinElmer Inc. today announced that the Company will present at the virtual KeyBanc Capital Markets Life Sciences & MedTech Investor Forum on Tuesday, March 21, 2023 at 2:15 p.m. ET.
March 9, 2023
·
1 min read
Press Releases
ABS Bio, Inc. announces strategic investment by 3 Boomerang Capital
◆Investment to support services growth. ◆Industry veterans join board of directors, including John Chickosky as Executive Chairman, and Greg Swanberg and Martin LeBlanc as Directors.
November 14, 2024
·
1 min read
Genetown
PerkinElmer to Present at 2022 Stifel Healthcare Conference
PerkinElmer Inc. today announced that the Company will present at the 2022 Stifel Healthcare Conference on Wednesday, November 16, 2022 at 9:10 a.m. ET in New York, NY.
November 10, 2022
·
1 min read
Business
PerkinElmer Board Declares Quarterly Dividend payable on February 10, 2023
The Board of Directors of PerkinElmer, Inc. declared a regular quarterly dividend of $0.07 per share of common stock.
October 26, 2022
·
1 min read
Genetown
PerkinElmer to Present at Upcoming Investor Conferences
PerkinElmer Inc. today announced that the Company will present at the 2022 Wells Fargo Healthcare Conference and the Baird’s 2022 Global Healthcare Conference.
August 24, 2022
·
1 min read
1 of 68,628
Next
